Cabozantinib,Nivolumab,Ipilimumab
Exelixis,bms
['triplet,(-triplete)', 'renal,(-adrenal)']
esmo 2022: triplet therapy improves outcomes in metastatic renal cell carcinoma #oncology
Official Twitter account of @PracticeUpdate Oncology. Includes commentaries, journal scans, conference coverage, news items & more. Part of Elsevier.